References
1. Moss B, Poxviridae: The viruses and their replication. in Fields
virology, Bernard N. Fields, David M. Knipe, Peter M. Howley, Editors.
2007, Lippincott Williams & Wilkins. p. 2333-2350.
2. Thornhill JP, Barkati S, Walmsley S, et al. Monkeypox Virus Infection
in Humans across 16 Countries - April-June 2022. N Engl J Med
2022;387(8):679-691.
3. Patel VM, Patel, SV. Epidemiological Review on Monkeypox. Cureus
2023;15(2):e34653.
4. Colavita F, Mazzotta V, Rozera G, et al. Kinetics of viral DNA in
body fluids and antibody response in patients with acute Monkeypox virus
infection. iScience 2023;26(3):106102.
5. Yon H, Shin H, Shin JI, et al. Clinical manifestations of human mpox
infection: A systematic review and meta-analysis. Rev Med Virol
2023;e2446. doi: 10.1002/rmv.2446.
6. Pilkington V, Quinn K, Campbell L, Payne L, Brady M, Post FA.
Clinical Presentation of Monkeypox in People With and Without HIV in the
United Kingdom During the 2022 Global Outbreak. AIDS Res Hum
Retroviruses 2023. doi: 10.1089/AID.2023.0014.
7. Vogel L. Making sense of monkeypox death rates. CMAJ
2022;194(31):E1097.
8. Eis-Hübinger AM, Gerritzen A, Schneweis KE, et al. Fatal cowpox-like
virus infection transmitted by cat. Lancet 1990;336(8719): 880.
9. Becker C, Kurth A, Hessler F, et al. Cowpox virus infection in pet
rat owners: not always immediately recognized. Dtsch Arztebl Int
2009;106(19):329-334.
10. Gilchuk I, Gilchuk P, Sapparapu G, et al. Cross-Neutralizing and
Protective Human Antibody Specificities to Poxvirus Infections. Cell
2016;167(3):684-694.e9.
11. Leendertz SAJ, Stern D, Theophil D, et al. A Cross-Sectional
Serosurvey of Anti-Orthopoxvirus Antibodies in Central and Western
Africa. Viruses 2017;9(10):278.
12. Zaeck LM, Lamers MM, Verstrepen BE, et al. Low levels of monkeypox
virus-neutralizing antibodies after MVA-BN vaccination in healthy
individuals. Nat Med 2023;29(1):270-278.
13. Gispen R, Huisman J, Brand-Saathof B, Hekker AC. Immunofluorescence
test for persistent poxvirus antibodies. Arch Gesamte Virusforsch
1974;44(4):391-395.
14. Lim CK, Roberts J, Moso M, et al. Mpox diagnostics: Review of
current and emerging technologies. J Med Virol 2023;95(1):e28429.
15. Dubois ME, Slifka MK. Retrospective analysis of monkeypox infection.
Emerg Infect Dis 2008;14(4):592-599.
16. Kurth A, Wibbelt G, Gerber HP, Petschaelis A, Pauli G, Nitsche A.
Rat-to-elephant-to-human transmission of cowpox virus. Emerg Infect Dis
2008;14(4):670-671.
17. Dubois ME, Hammarlund E, Slifka MK. Optimization of peptide-based
ELISA for serological diagnostics: a retrospective study of human
monkeypox infection. Vector Borne Zoonotic Dis 2012;12(5):400-409.
18. Newman FK, Frey SE, Blevins TP, et al. Improved assay to detect
neutralizing antibody following vaccination with diluted or undiluted
vaccinia (Dryvax) vaccine. J Clin Microbiol 2003;41(7):3154-3157.
19. Kramski M, Drozd A, Lichtfuss GF, Dabrowski PW, Ellerbrok H. Rapid
detection of anti-Vaccinia virus neutralizing antibodies. Virol J
2011;8:139.
20. Earl PL, Americo JL, Moss B. Development and use of a vaccinia virus
neutralization assay based on flow cytometric detection of green
fluorescent protein. J Virol 2003;77(19):10684-10688.
21. Sanz H, Aponte JJ, Harezlak J, et al. drLumi: An open-source package
to manage data, calibrate, and conduct quality control of multiplex
bead-based immunoassays data analysis. PLoS One 2017;12(11):e0187901.
22. Haddock E, Feldmann F, Feldmann H. Effective Chemical Inactivation
of Ebola Virus. Emerg Infect Dis 2016;22(7):1292-1294.
23. Poelsler G, Berting A, Kindermann J, et al. A new liquid intravenous
immunoglobulin with three dedicated virus reduction steps: virus and
prion reduction capacity. Vox Sang 2008;94(3):184-192.
24. Michel J, Targosz A, Rinner T, et al., Evaluation of 11 commercially
available PCR kits for the detection of monkeypox virus DNA, Berlin,
July to September 2022. Euro Surveill 2022;27(45):2200816.
25. Marennikova SS, Malceva NN, Habahpaseva NA. ELISA–a simple test
for detecting and differentiating antibodies to closely related
orthopoxviruses. Bull World Health Organ 1981;59(3):365-369.
26. Criscuolo E, Giuliani B, Ferrarese R, et al. Smallpox
vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus
Clade II. J Med Virol 2023;95(3):e28643.
27. Cummings JF, Polhemus ME, Hawkes C, Klote M, Ludwig GV, Wortmann G.
Lack of vaccinia viremia after smallpox vaccination. Clin Infect Dis
2004;38(3):456-458.
28. Likos AM, Sammons SA, Olson VA, et al. A tale of two clades:
monkeypox viruses. J Gen Virol 2005;86(Pt 10):2661-2672.
39. Hutson CL, Carroll DS, Gallardo-Romero N, et al.
Comparison of Monkeypox Virus
Clade Kinetics and Pathology within the Prairie Dog Animal Model Using a
Serial Sacrifice Study Design. Biomed Res Int 2015;2015:965710.
30. Nitsche A, Kurth A, Pauli G. Viremia in human Cowpox virus
infection. J Clin Virol 2007;40(2):160-162.